JosephIngrassiaMDFACC
Cardiology • Hartford, CTInterventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Interventional Cardiologist, Director Vascular Medicine and Endovascular Intervention
Dr. Ingrassia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
85 Seymour St
Hartford, CT 06106
Summary
- Dr. Joseph Ingrassia is an interventional cardiologist based in Hartford, CT. He graduated in 2011 and has contributed to several publications on topics like myocardial infarction, pulmonary embolism intracardiac masses, and COVID-19's impact on cardiology, with his works being cited by other researchers. Dr. Ingrassia is also the principal investigator in the SPYRAL AFFIRM Global Study, which explores renal denervation systems in patients with uncontrolled hypertension. In addition he is the principal investigator in the AVENTUS Clinical Trial, The QUADRA -PE Trial and the Spirare II: PE Clinical Trial, all involving pulmonary embolism thrombectomy devices.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Interventional Cardiology, 2019 - 2020
University of Connecticut/Hartford HospitalFellowship, Interventional Cardiology, 2018 - 2019- University of ConnecticutFellowship, Cardiovascular Disease, 2015 - 2018
- University of ConnecticutChief Residency, Internal Medicine, 2014 - 2015
- University of ConnecticutResidency, Internal Medicine, 2011 - 2014
Ross University School of MedicineClass of 2011
Certifications & Licensure
CT State Medical License 2017 - 2025
NY State Medical License 2019 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN Start of enrollment: 2021 Oct 20
Roles: Contact, Principal Investigator
- Aventus Thrombectomy System Pulmonary Embolism Clinical Study Start of enrollment: 2023 Sep 20
- Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I Start of enrollment: 2024 Sep 10
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCharacteristics and outcomes of angiovac-assisted debulking of intracardiac masses, thrombi, and endocarditis.Haris Patail, Mohiuddin Cheema, Raymond McKay, Joseph Ingrassia
Clinical Research in Cardiology. 2023-05-01 - 1 citationsRecovery From the Impact of COVID-19 on Treatment Times and Clinical Outcomes of Patients With ST-Segment Elevation Myocardial Infarction: An Interim Analysis.Abdelrahman Ali, Thomas Schirmer, Francis J Kiernan, Bryan Piccirillo, Joseph Ingrassia
Texas Heart Institute Journal. 2023-03-01 - 1 citationsImpact of Ticagrelor Versus Clopidogrel on Bleeding Outcomes of Isolated Coronary Artery Bypass Grafting.Joseph J Ingrassia, Wassim Mosleh, Chad M Conner, Jeffrey F Mather, Deborah S Loya
Cardiovascular Revascularization Medicine. 2023-01-01
Professional Memberships
- Member
- Society for Cardiovascular Angiography & InterventionsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
